Transgenic Group (TSE:2342) Dividend Payout Ratio: 0.00 (As of Mar. 2026)


TSE:2342 Transgenic Group Inc TSE:2342
61 GF Score
Price 円226.00
GF Value 円257.72
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Dividend Payout Ratio?

Transgenic Group TSE:2342 +5.61% 61 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 61/100 and a GF Value™ of 円257.72 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 133 Biotechnology companies, Transgenic Group ranks worse than 751878.95% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Transgenic Group's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

The historical rank and industry rank for Transgenic Group's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Transgenic Group was 1.71. The lowest was 0.04. And the median was 0.08.

TSE:2342's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-07-11), the Dividend Yield % of Transgenic Group is 0.00%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Transgenic Group was 1.73%. The lowest was 0.00%. And the median was 0.96%.

Transgenic Group's Dividends per Share for the months ended in Mar. 2026 was 円0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Transgenic Group (TSE:2342) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Transgenic Group Dividend Payout Ratio Related Terms


Transgenic Group Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Dividend Payout Ratio Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.00 1.71 0.00 0.00

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:2342 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Transgenic Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Transgenic Group's Dividend Payout Ratio falls into.


TSE:2342
61GF Score
Transgenic Group Inc TSE:2342
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Transgenic Group's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=0/ 6.921
=0.00

Transgenic Group's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 3.31
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Transgenic Group (TSE:2342) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Transgenic Group and its competitors. Over the past decade, Transgenic Group's Dividend Payout Ratio has ranged from 0.04 to 1.71. According to the industry distribution chart, Transgenic Group ranks #999999 out of 133 companies in the Biotechnology industry.
Is Transgenic Group's Dividend Payout Ratio too high?
Transgenic Group's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 1.71. Based on the distribution chart, Transgenic Group ranks #999999 out of 133 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Transgenic Group has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Transgenic Group ranks #999999 out of 133 companies for Dividend Payout Ratio. This places Transgenic Group in the lower half of its industry. The industry median Dividend Payout Ratio is 0.44. Historically, Transgenic Group's own Dividend Payout Ratio has ranged from 0.04 to 1.71 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Transgenic Group and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Transgenic Group's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.72, compared to a current price of 円226.00 — trading 12.3% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Transgenic Group's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円226.00 is trading 12.3% below its estimated GF Value™ of 円257.72. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Dividend Payout Ratio: 0.00
  • GF Value™: 円257.72 vs. price of 円226.00 (12.3% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
61GF Score

Get the complete analysis for TSE:2342

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円226.00
Price
円257.72
GF Value